ISOLYSER CO INC /GA/
10-K/A, 1997-06-13
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: BRANDES INVESTMENT TRUST, 485BPOS, 1997-06-13
Next: FRANKFORT FIRST BANCORP INC, 8-K, 1997-06-13



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-K/A
                                 Amendment No. 1
                  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For the Fiscal Year Ended December 31, 1996      Commission File Number: 0-24866
                          -----------------                              -------

                             ISOLYSER COMPANY, INC.
             (Exact Name of registrant as specified in its charter)

                 GEORGIA                                          58-1746149
(State or other jurisdiction of                              (I.R.S. Employer
 incorporation or organization)                              Identification No.)


650 ENGINEERING DRIVE
TECHNOLOGY PARK
NORCROSS, GEORGIA                                                 30092
(Address of principal executive offices)                        (Zip Code)


                                 (770) 582-6363
               Registrant's telephone number, including area code

           Securities registered pursuant to Section 12(b) of the Act:
                                      None

           Securities registered pursuant to Section 12(g) of the Act:
                     common stock, $.001 par value per share
                              stock purchase rights


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X      No

Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]

The  aggregate  market  value  of  common  stock  held by  nonaffiliates  of the
registrant  based on the sale trade price of the common stock as reported on The
Nasdaq Stock Market on March 27, 1997, was  approximately  $165.4  million.  For
purposes of this computation,  all officers,  directors and 5% beneficial owners
of the registrant are deemed to be affiliates.  Such determination should not be
deemed an admission that such officers,  directors or 5% beneficial  owners are,
in fact, affiliates of the registrant.

At March 27, 1997, there were outstanding  39,207,668 shares of the registrant's
common stock, $.001 par value per share.

Documents incorporated by reference:  Portions of the Company's definitive proxy
statement for the annual meeting of shareholders  are  incorporated by reference
into  Part  III.  Certain  exhibits  provided  in  Part IV are  incorporated  by
reference  from the  Company's  Registration  Statements  on Form S-1 (File Nos.
33-83474 and 33-97086),  Registration Statement on Form S-4 (File No. 333-7977),
Registration  Statement on Form S-8 (File Nos. 33-85668),  annual report on Form
10-K for the periods ended December 31, 1994, and December 31, 1995, and current
reports on Form 8-K dated May 31, 1995, September 18, 1995, June 4, 1996, August
30, 1996 and December 19, 1996.



438869.1

<PAGE>



         Note:  The  discussions  in the Form  10-K and this  Amendment  contain
forward  looking  statements  that involve risks and  uncertainties.  The actual
results of Isolyser Company,  Inc. and subsidiaries (the "Company") could differ
significantly  from  those  set  forth  herein.  Factors  that  could  cause  or
contribute to such differences  include, but are not limited to, those discussed
in  "Business",  particularly  "Business  -- Risk  Factors",  and  "Management's
Discussion  and Analysis of Financial  Condition and Results of  Operations"  as
well as those discussed elsewhere in the Form 10-K.  Statements contained in the
Form 10-K and this Amendment that are not historical  facts are forward  looking
statements that are subject to the safe harbor created by the Private Securities
Litigation  Reform Act of 1995.  A number of important  factors  could cause the
Company's  actual  results for 1997 and beyond to differ  materially  from those
expressed or implied in any forward looking statements made by, or on behalf of,
the  Company.  These  factors  include,  without  limitation,  those  listed  in
"Business -- Risk Factors" in the Form 10-K.

         Subsequent  to filing  the  Annual  Report on Form 10-K for the  period
ending December 31, 1996 ("Form 10-K") of Isolyser Company, Inc. (the "Company")
and during 1996,  the Company  changed  certain of its  directors  and executive
officers.  Accordingly,  effective May 1, 1997 the undersigned registrant hereby
amends Part III of its Annual Report on Form 10-K as set forth below:





438869.1
                                        2

<PAGE>



                                    PART III


         ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

         The information  contained in the Company's  definitive proxy statement
dated May 1, 1997 (the  "Proxy  Statement")  under the  caption  "Directors  and
Executive  Officers"  is  incorporated  herein by  reference in response to this
item.

         ITEM 11. EXECUTIVE COMPENSATION

         The  information  contained  in the Proxy  Statement  under the caption
"Executive Compensation" is incorporated herein by reference in response to this
item,  exclusive of the  information  contained in the Proxy Statement under the
captions "Report of the Compensation  Committee on Executive  Compensation"  and
"Stock Price Performance Graph".

         ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
                  MANAGEMENT

         The  information  in the Proxy  Statement  contained  under the caption
"Security Ownership of Certain Beneficial Owners and Management" is incorporated
herein by reference in response to this item.

         ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

         The Company has no information to report pursuant to this Item.


                                     PART IV

     ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

(a)         (1) and (2) - Financial Statements and Schedules

            The following  financial  statements and schedules included on pages
F-1 through F-23 are filed as part of this annual report.

             Consolidated Financial Statements and Independent Auditors' Report:


                    Independent Auditors' Report
                    Consolidated Balance Sheets as of December 31, 1996 and 1995
                    Consolidated Statements of Operations for the years
                    ended December 31, 1996, 1995 and 1994 Consolidated
                    Statements of Changes in  Shareholders'  Equity for
                    the years ended  December 31,  1996,  1995 and 1994
                    Consolidated Statements of Cash Flows for the years
                    ended December 31, 1996, 1995 and 1994 Notes to the
                    Consolidated Financial Statements



                  Financial Statement Schedules:

                           Schedule II - Valuation and Qualifying Accounts

                  Other  schedules are omitted  because they are not applicable,
                not required or because required  information is included in the
                consolidated financial statements or notes thereto.

             (3) Exhibits

<TABLE>
<CAPTION>

<C>          <C>
2.1          Articles of Merger of MedSurg Industries, Inc. and MedSurg Acquisition Corp. dated December 31, 1993
             (incorporated by reference to Exhibit 2.1 filed with the Company's Registration Statement on Form S-1, File No. 33-
             83474)
2.2          Plan and Agreement of Merger dated December 31, 1993 of MedSurg Industries, Inc. and MedSurg Acquisition Corp.
             (incorporated by reference to Exhibit 2.2 filed with the Company's Registration Statement on Form S-1, File No. 33-
             83474)
2.3          Certificate of Merger and Name Change of MedSurg Industries, Inc. and MedSurg Acquisition Corp. dated January
             7, 1994 (incorporated by reference to Exhibit 2.3 filed with the Company's Registration Statement on Form S-1, File
             No. 33-84374)

438869.1
                                        3

<PAGE>

2.4          Articles of Merger of Creative Research and Manufacturing, Inc. and Creative Acquisition Corp. dated December 31,
             1993 (incorporated by reference to Exhibit 2.4 filed with the Company's Registration Statement on Form S-1, File
             No. 33-83474)
2.5          Plan and Agreement of Merger dated December 31, 1993 of Creative Research and Manufacturing, Inc. and Creative
             Acquisition Corp. (incorporated by reference to Exhibit 2.5 filed with the Company's Registration Statement on Form
             S-1, File No. 33-83474)
2.6          Certificate of Merger and Name Change of Creative Research and Manufacturing, Inc. and Creative Acquisition Corp.
             dated January 7, 1994 (incorporated by reference to Exhibit 2.6 filed with the Company's Registration Statement on
             Form S-1, File No. 33-83474)
2.7          Agreement and Plan of Merger dated as of July 28, 1995 among the Company, White Knight Acquisition Corp. and
             White Knight Healthcare, Inc. (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form
             8-K filed October 3, 1995)
2.8          Agreement and Plan of Merger dated as of May 1, 1995 among the Company, Isolyser/SafeWaste Acquisition Corp.
             and SafeWaste Corporation (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K
             filed on June 15, 1995)
2.9          Articles of Merger dated May 31, 1995 of SafeWaste Corporation With and Into  Isolyser/SafeWaste  Acquisition  Corp.
             (incorporated  by reference to Exhibit 2.2 to the  Company's  Current  Report on Form 8-K filed on June 15, 1995)
2.10         Certificate of Merger dated May 31, 1995 of Isolyser/SafeWaste Acquisition Corp. and SafeWaste Corporation
             (incorporated by reference to Exhibit 2.3 to the Company's Current Report on Form 8-K filed on June 15, 1995)
2.11         Articles  of Merger of White  Knight  Healthcare,  Inc.,  and White Knight Acquisition Corp., dated September 18, 1995
             (incorporated by reference to Exhibit 2.2 to the  Company's  Current  Report on Form 8-K filed on October 3, 1995)
2.12         Certificate of Merger of White Knight  Healthcare,  Inc., and White Knight Acquisition Corp., dated September 18, 1995
             (incorporated by reference to Exhibit 2.3 to the  Company's  Current  Report on Form 8-K filed October 3, 1995)
2.13         Stock Purchase Agreement dated December 31, 1993 between the Company, MedSurg Acquisition Corp., Creative
             Acquisition Corp., MedSurg Industries, Inc., Creative Research and Manufacturing, Inc. and MedInvest Enterprises,
             Inc. (incorporated by reference to Exhibit 2.7 to the Company's Registration Statement on Form S-1, File No. 33-
             83474)
2.14         Agreement and Plan of Merger dated March 15, 1996 among the Company, Microtek Medical, Inc. and MMI Merger
             Corp. (incorporated by reference to the Joint Proxy Statement/Prospectus included in the Company's Registration
             Statement on Form S-4, File No. 333-7977).
3.1          Articles of Incorporation of Isolyser Company, Inc. (incorporated by reference to Exhibit 3.1 filed with the Company's
             Registration Statement on Form S-1, File No. 33-83474).
3.2*         Articles of Amendment to Articles of Incorporation of Isolyser Company, Inc.
3.3          Amended and Restated Bylaws of Isolyser Company, inc. (incorporated by reference to Exhibit 3.2 filed with the
             Company's Registration Statement on Form S-1, File No. 33-83474)
3.4          First Amendment to Amended and Restated Bylaws of Isolyser Company, Inc. (incorporated by reference to Exhibit
             3.1 to the Company's Current Report on Form 8-K filed July 29, 1996).
3.5          Second Amendment of Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company's
             Current Report on Form 8-K filed December 20, 1996).
4.1          Specimen Certificate of Common Stock (incorporated by reference to Exhibit 4.1 filed with the Company's
             Registration Statement on Form S-1, File No. 33-83474)
4.2          Shareholder Protection Rights Agreement dated as of December 20, 1996 between Isolyser Company, Inc. and
             SunTrust Bank (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on
             December 20, 1996).
10.1         Stock Option Plan and First Amendment to Stock Option Plan (incorporated by reference to Exhibit 4.1 filed with the
             Company's Registration Statement on Form S-8, File No. 33-85668)
10.2         Second Amendment to Stock Option Plan (incorporated by reference to Exhibit 4.1 filed with the Company's
             Registration Statement on Form S-8, File No. 33-85668)
10.3         Form of Third Amendment to Stock Option Plan (incorporated by reference to Exhibit 10.37 filed with the Company's
             Annual Report on Form 10-K for the period ended December 31, 1994)
10.4         Form of Fourth Amendments to the Stock Option Plan (incorporated by reference to Exhibit 10.59 filed with the Company's
             Annual Report on Form 10-K for the period ended December 31, 1995).
10.5*        Form of Fifth Amendment to Stock Option Plan.
10.6         Form of Incentive Stock Option Agreement pursuant to Stock Option Plan (incorporated by reference to Exhibit 4.2
             filed with the Company's Registration Statement on Form S-8, File No. 33-85668)
10.7         Form of Non-Qualified Stock Option Agreement pursuant to Stock Option Plan (incorporated by reference to Exhibit
             4.3, filed with the Company's Registration Statement on Form S-8, File No. 33-85668)
10.8         Form of Option for employees of the Company outside of Stock Option Plan (incorporated by reference to Exhibit
             10.6 filed with the Company's Registration Statement on Form S-1, File No. 33-83474)
10.9*        Employment Agreement of Lester J. Berry.
10.10        Lease Agreement, dated July 29, 1993, between Richard E. Curtis, Trustee and MedSurg Industries, Inc.
             (incorporated by reference to Exhibit 10.25 filed with the Company's Registration Statement on Form S-1, File No.
             33-83474)
10.11        First Lease Amendment, dated February 28, 1994, between Richard E. Curtis, Trustee and MedSurg Industries, Inc.
             (incorporated by reference to Exhibit 10.26 filed with the Company's Registration Statement on Form S-1, File No.
             33-83474)
10.12        Lease Agreement, dated October 21, 1991, between Weeks Master Partnership, L.P. and the Company (incorporated
             by reference to Exhibit 10.27 filed with the Company's Registration Statement on Form S-1, File No. 33-83474)
10.13        Lease, dated September 28, 1984, between M.S.I. Limited Partnership and MedSurg Industries, Inc. (incorporated
             by reference to Exhibit 10.28 filed with the Company's Registration Statement on Form S-1, File No. 33-83474)

438869.1
                                        4

<PAGE>



10.14        Amendment No. 1 to Lease, dated October 10, 1984, between M.S.I. Limited Partnership and MedSurg Industries,
             Inc. (incorporated by reference to Exhibit 10.29 filed with the Company's Registration Statement on Form S-1, File
             No. 33-83474)
10.15        Agreement and Second Amendment to Lease, dated December 31, 1993, between M.S.I. Limited Partnership and
             MedSurg Industries, Inc. (incorporated by reference to Exhibit 10.30 filed with the Company's Registration Statement
             on Form S-1, File No. 33-83474)
10.16        Third Amendment to Lease, dated September 9, 1994, between M.S.I. Limited Partnership nd Medsurg Industries,
             Inc. (incorporated by reference to Exhibit 10.31 filed with the Company's Registration Statement on Form S-1, File
             No. 33-83474)
10.17        Lease Agreement, dated October 4, 1990, between Minnetonka Business Associates and Creative Research and
             Manufacturing, Inc. (incorporated by reference to Exhibit 10.35 filed with the Company's Registration Statement on
             Form S-1, File No. 33-83474)
10.18        Agreement to Extend Lease, dated October 7, 1991, between Minnetonka Business Associates and Creative Research
             and Manufacturing, Inc. (incorporated by reference to Exhibit 10.36 filed with the Company's Registration Statement
             on Form S-1, File No. 33-83474)
10.19        Agreement to Extend Lease, dated June 23, 1993, between Minnetonka Business Associates and Creative Research
             and Manufacturing, Inc. (incorporated by reference to Exhibit 10.37 filed with the Company's Registration Statement
             on Form S-1, File No. 33-83474)
10.20        Agreement to Extend Lease dated June 27, 1995, between 7100 Building Company Limited Partnership and Creative
             Research and Manufacturing, Inc. (incorporated by reference to Exhibit 10.27 filed with the Company's Registration
             Statement on Form S-1 File No. 33-97086)
10.21        Form of Indemnity Agreement entered into between the Company and certain of its officers and directors (incorporated
             by reference to Exhibit 10.45 filed with the Company's Registration Statement on Form S-1, File No. 33-83474)
10.22        Amended and Restated Credit Agreement dated as of August 30, 1996, among the Company, MedSurg,  Microtek, White Knight,
             the Guarantors named  therein,  the Lenders named therein and The Chase  Manhattan Bank  (incorporated  by referenced
             to Exhibit 10.1 of the Company's Current Report on Form 8-K filed on September 13, 1996).
10.23        Lease  Agreement,  dated  November 18, 1994,  between Weeks Realty, L.P. and the Company  (incorporated  by reference
             to Exhibit  10.38 filed with the Company's  Annual Report on Form 10-K for the period ended December 31, 1994)
10.24        1995 Nonemployee Director Stock Option Plan (incorporated by reference to Exhibit 10.39 filed with the Company's
             Annual Report on Form 10-K for the period ended December 31, 1994)
10.25        Agreement and Lease dated October 1, 1992 between Industrial Development Authority of the City of Douglas,
             Arizona and White Knight Healthcare, Inc. (incorporated by reference to Exhibit 10.41 filed with the Company's
             Registration Statement on Form S-1 File No. 33-97086)
10.26        Product Purchase and Supply Agreement dated February 8, 1993 between White Knight Healthcare, Inc. and Sterile
             Concepts, Inc. (incorporated by reference to Exhibit 10.42 filed with the Company's Registration Statement on Form
             S-1 File No. 33-97086)
10.27        Non-Negotiable Promissory Note in the original principal amount of $2,304,000.00 dated February 8, 1993 between
             White Knight Healthcare, Inc. and Sterile Concepts, Inc. (incorporated by reference to Exhibit 10.43 filed with the
             Company's Registration Statement on Form S-1 File No. 33-97086)
10.28        Non-Negotiable Promissory Note in the original principal amount of $1,278,500.00 dated February 8, 1993 between
             White Knight Healthcare, Inc. and Sterile Concepts, Inc. (incorporated by reference to Exhibit 10.44 filed with the
             Company's Registration Statement on Form S-1 File No. 33-97086)
10.29        Form of  Non-Negotiable  Promissory Note in the original  Principal amount of $750,000 dated September 15, 1995 between
             the Company and Ali R. Momtaz  (incorporated  by reference  to Exhibit  10.46 filed with  the  Company's  Registration
             Statement  on Form S-1 File No. 33-97086)
10.30        Distribution  and  Marketing  Agreement  dated  September  15, 1995 between the Company and Sterile  Concepts,  Inc.
             (incorporated  by reference to Exhibit  10.48 filed with the  Company's  Registration Statement on Form S-1 File No.
             33-97086)
10.31        Agreement, dated November 1, 1992 between Struble & Moffitt Company and United Food and Commercial Workers Union Local
             1360, chartered by United Food and Commercial  Workers,  AFL-CIO  (incorporated  by reference to Exhibit  10.49 filed
             with the  Company's  Registration Statement on Form S-1 File No. 33-97086)
10.32        Agreement,  dated  March 18, 1995  between  White  Knight  Hospital Disposables  and  United  Food and  Commercial 
             Workers  Local  99R (incorporated   by  reference  to  Exhibit  10.50  filed  with  the Company's Registration
             Statement on Form S-1 File No. 33-97086)
10.33        Labor Contract, dated July 22, 1994, between Union of Industrial, Related and Similar Workers of the Municipality
             of Agua Prieta, Sonora, C.R.O.M. and Industrias Apson, S.A. de C.V. (incorporated by reference to Exhibit 10.51
             filed with the Company's Registration Statement on Form S-1 File No. 33-97086)
10.34        Lease Agreement dated June 21, 1995 between Caballeros Blanca, S.A. de C.V. and Constuctora Immobiliaria del
             Norte de Doahuila, S.A. de C.V. (incorporated by reference to Exhibit 10.53 filed with the Company's Registration
             Statement on Form S-1 File No. 33-97086)
10.35        Lease, dated August 1, 1987, between HARP, a division of M.B. Haynes Electric Corporation, and Mars/White
             Knight, a division of Work Wear Corporation, Inc., as amended by Addendum No. 1 dated July 6, 1987, Addendum
             No. 2 dated July 6, 1987, Addendum No. 3 dated May 14, 1990, Addendum No. 4, dated June 17, 1992, second
             Addendum No.4 dated June 28, 1993, Addendum No. 5 dated May 26, 1994, Addendum No. 6 dated July 11, 1995,
             and Addendum No. 7 dated September 202, 1995 (incorporated by reference to Exhibit 10.55 filed with the
             Company's Registration Statement on Form S-1 File No. 33-97086)
10.36        Lease,  dated October 1, 1995,  between  SafeWaste  Corporation and Highwoods/Forsyth Limited Partnership (incorporated
             by reference to Exhibit  10.56 filed with the Company's  Registration  Statement on Form S-1 File No. 33-97086)

438869.1
                                        5

<PAGE>



10.37        1995 Employee Stock Purchase Plan, as amended by First Amendment dated July 1, 1995 (incorporated by reference
             to Exhibit 10.57 filed with the Company's Registration Statement on Form S-1 File No. 33-97086)
10.38        Second Amendment to 1995 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.58 to the
             Company vs. Annual Report on Form 10-K for the period ended December 31, 1995)
10.39*       Third Amendment to 1995 Employee Stock Purchase Plan
10.40        Asset Exchange Agreement dated July, 1995 between Microtek and Xomed, Inc. (incorporated by reference to Exhibit
             10.9 to Microtek's Annual Report on Form 10-K for the period ended November 30, 1995).
10.41        Asset Purchase Agreement dated November 30, 1995 among Microtek, Medi-Plast International, Inc. and certain
             affiliates of Medi-Plast International, Inc. (incorporated by reference to Microtek's Current Report on Form 8-K dated
             December 8, 1995).
10.42        Asset Purchase Agreement dated April 27, 1996 between Microtek and Advanced Instruments, Inc. (incorporated by
             reference to Exhibit 2.1 to Microtek's Current Report on Form 8-K dated May 15, 1996).
10.43        Employment Agreement dated December 31, 1993 between Michael Sahady MedSurg Industries, Inc., Creative
             Research and Manufacturing, Inc. and the Company (incorporated by reference to Exhibit 10.1 filed with the
             Company's Registration Statement on Form S-1, File No. 33-83474).
10.44        Amendment to Employment Agreement dated as of May 24, 1996 between Michael Sahady, MedSurg Industries, Inc.,
             Creative Research and Manufacturing, Inc. and the Company.
10.45        Employment Agreement dated December 31, 1993 between Kenneth Newsome, MedSurg Industries, Inc., Creative
             Research and Manufacturing, Inc. and the Company (incorporated by reference to Exhibit 10.2 filed with the
             Company's Registration Statement on Form S-1, File No. 33-83474)
10.46        Amendment to Employment Agreement dated as of December 31, 1996 between Kenneth Newsome, MedSurg
             Industries, Inc., Creative Research and Manufacturing, Inc. and the Company.
10.47        Form of Sixth Amendment of Isolyser Company, Inc. Stock Option Plan
11.1*        Statement re: computation of per share earnings
21.1*        Subsidiaries of the Company
23.1*        Consent of Deloitte & Touche LLP
23.2*        Consent of KPMG Peat Marwick LLP
27.1*        Financial Data Schedule
</TABLE>

*            Previously filed


(b)          Reports on Form 8-K:

                (1)  Form 8-K, dated December 19, 1996, regarding Other Events






438869.1
                                        6

<PAGE>


                                   SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized on June 11, 1997.

                                    ISOLYSER COMPANY, INC.



                                    By:   Gene R. McGrevin
                                          Gene R. McGrevin, President

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
this report has been signed by the following persons on behalf of the registrant
in the capacities indicated on June 11, 1997.

SIGNATURE                           TITLE



Gene R. McGrevin                           President
Gene R. McGrevin                           Chairman of the Board of Directors
                                           (principal executive officer)


Peter Schmitt                              Vice President of Finance,
Peter Schmitt                              Chief Financial Officer and Treasurer
                                           (principal financial and accounting
                                           officer)


Travis W. Honeycutt                        Executive Vice President,
Travis W. Honeycutt                        Secretary and Director



Dan R. Lee                                 Executive Vice President
Dan R. Lee                                 and Director



Rosdon Hendrix                             Director
Rosdon Hendrix



Kenneth F. Davis                           Director
Kenneth F. Davis



Olivia F. Kirtley                          Director
Olivia F. Kirtley



438869.1
                                        7

                        AMENDMENT TO EMPLOYMENT AGREEMENT

         THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this "Amendment") is
made and entered  into as of the 24th day of May,  1996,  by  Isolyser  Company,
Inc., a Georgia corporation (hereinafter "Isolyser"),  MedSurg Industries, Inc.,
a Georgia corporation  formerly known as MedSurg Acquisition Corp.  (hereinafter
"MedSurg"),  Creative Research and  Manufacturing,  Inc., a Georgia  corporation
formerly known as Creative Acquisition Corp.  (hereinafter  "Creative Research")
(Isolyser, MedSurg and Creative Research being hereinafter collectively referred
to as the "Company"), and Michael Sahady (hereinafter "Sahady").

                              W I T N E S S E T H:

         WHEREAS,  the Company and Sahady entered into an Employment  Agreement,
dated as of December 31, 1993 (the "Employment Agreement"); and

         WHEREAS,  Sahady has  elected to resign his  position  as an  executive
officer of the Company and the Company has accepted such resignation; and

         WHEREAS,  the  Company  and  Sahady  desire  to  amend  the  Employment
Agreement, upon the terms and conditions set forth herein.

         NOW,  THEREFORE,  for  and in  consideration  of the  mutual  covenants
contained  herein,  the parties  hereto,  each intending to be legally bound, do
hereby agree as follows:

         1.       Change in Relationship.

                  (a) Upon the terms and conditions set forth in this Amendment,
Sahady hereby resigns and the Company  hereby accepts the  resignation of Sahady
as an Executive  Vice  President  of Isolyser  and the  President of MedSurg and
Creative Research.

                  (b) Sahady hereby  resigns as a director of Isolyser,  MedSurg
and Creative  Research.  Sahady has  concurrently  executed and delivered to the
Company his letter of resignation  from such  directorships in the form attached
hereto at Exhibit A and incorporated herein by reference.

                  (c) For the  balance of the term of the  Employment  Agreement
(namely, through December 31, 1996) and continuing thereafter until December 31,
1997,  Sahady  shall  continue  as an  employee  of  Isolyser  with the title of
"Special Assistant to the Chief Executive". As such, he shall assist the Company
faithfully and diligently to achieve its business objectives as may from time to
time be requested by the president and chief executive officer of Isolyser,  and
shall  take no  action  which  would be  contrary  to such  objectives.  Sahady,
however,  shall not be required to perform duties at variance to duties assigned
to senior executive level personnel of the Company.  As such Special  Assistant,
Sahady shall no longer have any  policy-making  or staff  authority on behalf of
the Company and shall have no authority to bind the Company to any obligations.


332647.1

<PAGE>



                  (d) Section 4 of the Employment  Agreement  captioned "Duties"
is hereby deleted.  Sahady shall not be required to devote his full working time
and  attention  to the  business  of  Isolyser,  and  may be  engaged  in  other
activities, to which he shall be entitled to devote a substantial portion of his
time.

          2. Compensation and Benefits. In lieu of all compensation and benefits
set forth in  Sections  5 and 7 of the  Employment  Agreement,  Sahady  shall be
entitled to the following:

                  (a) A  base  salary  as  set  forth  in  Section  5(a)  of the
Employment  Agreement in the amount of $175,000  per year through and  including
December  31,  1997  so  long  as  Sahady  is not in  breach  of the  Employment
Agreement, as herein amended, or Non-Compete (as hereinbelow defined), as now or
hereafter amended,  following five days notice of any such breach by Isolyser to
Sahady.

                  (b) The  fringe  benefits  set  forth in  Section  5(c) of the
Employment   Agreement   through  and  including   December  31,  1996.   Sahady
acknowledges  and agrees that all such fringe benefits shall cease and terminate
at December 31, 1996  notwithstanding  Sahady's continued employment as provided
in this Amendment  through and including  December 31, 1997,  except that Sahady
shall continue to be eligible for  participation  in the Company's  group health
insurance,  life insurance and  disability  insurance on the same basis as other
Company  employees  through  December  31, 1997.  Isolyser  shall  maintain,  at
Isolyser's  sole  cost and  expense,  the  additional  life  insurance  policies
identified  in the  last  three  sentences  of  Section  5(c) of the  Employment
Agreement,  through and including December 31, 1996, and effective as of January
1, 1997, the Company shall assign all rights to such policies to Sahady, without
charge to Sahady. The Company shall have no obligation in respect to any of such
policies subsequent to December 31, 1996.

                  (c) The sum of $27,073.88,  subject to applicable withholding,
in  satisfaction  of all accrued but unused paid absences due to Sahady  through
the date hereof. From and after the date hereof,  Sahady agrees that he shall no
longer accrue paid absences or be entitled to compensation for same.

                  (d) The  obligation  of the Company to pay the base salary set
forth in Section 2(a) of this  Amendment is not  conditional  upon, and shall be
payable through  December 31, 1997,  notwithstanding  the death or disability of
Sahady.

         3. Protective  Covenants.  Section 10(e)of the Employment Agreement and
Section  1  of  that  certain   Covenant  and  Agreement  Not  to  Compete  (the
"Non-Compete")  dated  December 31,  1993,  by Sahady and others in favor of the
Company are and shall hereby be terminated prospectively from and after the date
hereof.  Sahady  acknowledges  and  agrees  that the  other  covenants  included
therein,  including,  without  limitation,  the covenants against  disclosure of
confidential  information and  solicitation of Company  employees and customers,
shall:


332647.1


                                       -2-

<PAGE>



                  (a) continue in full force and effect and are hereby ratified
and confirmed by Sahady, and

                  (b) survive  this  Amendment in  accordance  with the terms of
such  covenants and shall be binding upon Sahady  through  December 31, 1998 (or
such longer  period as may be  applicable  for the  protection  of  confidential
information or trade secrets).

         4.       Other Matters.

                  (a) Section 6 of the Employment  Agreement captioned "Working
Facilities" is hereby deleted.

                  (b) Sahady  acknowledges  that he has  submitted  vouchers and
received  reimbursement  for all  business  expenses  to  which  he is  entitled
reimbursement  under Section 7 of the  Employment  Agreement.  The Company shall
have no further obligations under Section 7 of the Employment Agreement,  except
the Company shall be obligated to reimburse  Sahady for any expenses  reasonably
and necessarily incurred by him in the carrying out of any services specifically
requested of Sahady by the President and Chief Executive Officer of Isolyser.

                  (c) This  Agreement  does not  modify or cancel  the terms and
provisions of any options (collectively, the "Stock Options") previously awarded
Sahady for the  purchase of common stock of  Isolyser,  and such  options  shall
remain in full force and effect without  modification or amendment.  The parties
acknowledge  and agree that Sahady's  employment  by the Company shall  continue
through and including December 31, 1997, and that such date, except in the event
of Sahady's  death,  will be the effective date for the  termination of Sahady's
employment under the Stock Options.

         5.       Releases.

                  (a) In consideration of the covenants of the Company contained
in this  Amendment,  Sahady hereby  irrevocably  and  unconditionally  releases,
waives, remises, forever discharges and agrees not to sue the Company and/or any
and all parent companies, divisions, subsidiaries,  affiliates and other related
entities of the  Company,  as well as each of the  Company's  past,  present and
future owners, directors, officers, employees, and the predecessors,  successors
and assigns of each of them in their personal or corporate  capacities,  and all
of their attorneys (collectively, the "Released Parties"), from and with respect
to any and all liabilities,  actions,  claims,  obligations,  damages, causes of
action,  contracts,  accounts,  agreements and demands of any nature  whatsoever
that  Sahady  has,  may have or may claim to have  against  any of the  Released
Parties,  whether  known or unknown,  liquidated or  unliquidated,  in law or in
equity, whether arising under any local, state or federal  constitutions,  laws,
rules or  regulations,  or under the common law or  statutory  law of the United
States  prohibiting  employment   discrimination  based  on  race,  color,  sex,
religion,  handicap disability,  national origin or any other protected category
or characteristic,  including the Civil Rights Act of 1964, the Civil Rights Act
of 1986 or 1871, the National Labor Relations Act or any other federal, state or
local

332647.1


                                       -3-

<PAGE>



human rights, civil rights or employment  discrimination statute,  including any
claim arising under the AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, as amended
("ADEA"),  any rules or  regulations  arising  under such laws,  and any and all
claims relating to Sahady's employment or termination  thereof,  including,  but
not limited to, any claims under the doctrines of  defamation,  libel,  slander,
invasion  of  privacy,  interference  with  contractual  relations,  or  implied
contracts arising from employee  handbooks,  policies,  manuals or statements of
procedure  and  wrongful  discharge,  it being the  intention of the Company and
Sahady to make  this  release  as broad and as  general  as the law  permits  to
include in addition to the  foregoing  all possible  claims which arose or might
arise out of contract or tort under state or federal law.

                  (b) In  consideration  of the covenants of Sahady contained in
this Amendment,  the Company hereby  irrevocably and  unconditionally  releases,
waives,  remises,  forever  discharges and agrees not to sue, or otherwise claim
payment  to be due to or from  Sahady,  his heirs or  personal  representatives,
arising out of Sahady's capacity as an employee, stockholder,  officer or former
officer,  from and with  respect to any and all  liabilities,  actions,  claims,
obligations,  damages,  causes of action,  contracts,  accounts,  agreements and
demands  of any  nature  whatsoever  that the  Company  or any of the  Company's
stockholders,  officers or employees  has, may have or may claim to have against
Sahady,  whether  known or unknown,  liquidated  or  unliquidated,  in law or in
equity, whether arising under any local, state or federal  constitutions,  laws,
rules or regulations, or under common law or statutory law of the United States,
and any and all claims  relating  to  Sahady's  employment,  including,  but not
limited  to, any claims  under the  doctrines  of  defamation,  libel,  slander,
invasion of privacy,  or interference with contractual  relations,  it being the
intention of the Company and Sahady to make this release as broad and as general
as the law permits to include in addition to the foregoing  all possible  claims
which arose or might arise out of contract or tort under state or federal law.

                  (c) Nothing contained in Subsection (a) or (b) of this Section
5 shall restrict or otherwise  impair in any manner the rights or obligations of
any parties  arising  under and by virtue of (i) the  Employment  Agreement,  as
amended by this  Amendment,  (ii) this Amendment,  (iii) that certain  Indemnity
Agreement effective as of October 20, 1994 between Isolyser and Sahady, (iv) the
Stock Options,  (v) the Non-Compete or (vi) any amendment or modification of any
of the foregoing.

         6. Return of Property.  Sahady hereby warrants and represents  that, as
of the date of this  Amendment,  Sahady  has  delivered  to the  Company  or its
designee (a) all keys to the Company's offices,  (b) all Company credit cards in
his  possession,  and (c) any Company  files,  records or  equipment  kept in or
maintained by him in his office or elsewhere (including all copies thereof).

         7. Workers'  Compensation.  Sahady  represents that, as of the date of
this  Amendment,  he has not, and agrees that he will not, make any claims under
Workers' Compensation Insurance with respect to Sahady's period of employment at
the Company.


332647.1


                                       -4-

<PAGE>



         8. Continuing  Obligations.  Except as otherwise  expressly modified by
this  Amendment,  the terms  and  conditions  of the  Employment  Agreement  and
Non-Compete shall continue to be in full force and effect.

         9.       Disclosure.

                  (A) SAHADY SHOULD  CAREFULLY  READ AND  UNDERSTAND  THE TERMS,
CONDITIONS AND EFFECTS OF THIS AMENDMENT.  THIS IS A LEGAL DOCUMENT,  AND SAHADY
IS  ADVISED  THAT  HE  SHOULD  CONSULT  WITH AN  ATTORNEY  BEFORE  SIGNING  THIS
AMENDMENT.

                  (B)  PURSUANT  TO THE TERMS OF THE ADEA,  SAHADY IS ADVISED TO
CONSIDER THIS AMENDMENT FOR A PERIOD OF AT LEAST  TWENTY-ONE (21) DAYS AFTER THE
DATE OF RECEIPT BEFORE SAHADY EXECUTES THIS  AMENDMENT.  AFTER SAHADY SIGNS THIS
AMENDMENT  AND RETURNS IT TO THE COMPANY,  SAHADY HAS SEVEN (7) CALENDAR DAYS IN
WHICH TO NOTIFY THE COMPANY THAT SAHADY HAS DECIDED TO WITHDRAW  HIS  ACCEPTANCE
OF THIS AMENDMENT. THIS AMENDMENT (OTHER THAN SECTION 1 WHICH IS EFFECTIVE) WILL
NOT BECOME EFFECTIVE OR ENFORCEABLE AND NO PAYMENTS WILL BE MADE HEREUNDER UNTIL
THE END OF THE SEVEN DAY REVOCATION  PERIOD,  AT WHICH TIME THE AMENDMENT  SHALL
BECOME EFFECTIVE AND ENFORCEABLE.

         10.      Miscellaneous.

                  (a) All  capitalized  terms which are not defined herein shall
have the meanings set forth in the Employment Agreement.

                  (b) Each  party  agrees  that he or it will  refrain  from any
communication  to third parties which  denigrates,  disparages or criticizes the
other party hereto.

                  (c)  This   Agreement  and  all  the  terms,   provisions  and
conditions  hereof  shall be  binding  upon and inure to the  benefit  of and be
enforceable by the heirs and personal representatives of Sahady.

                  (d) The Company and Sahady  represent  that, as of the date of
execution  and  delivery  of this  Amendment  by each of them,  no breach of the
Employment Agreement, as amended by this Amendment, has occurred which is within
the actual knowledge of the parties so representing.



                         [SIGNATURES ON FOLLOWING PAGE]


332647.1


                                       -5-

<PAGE>



         IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed and delivered as of the date first above written.

                                                     ISOLYSER COMPANY, INC.



                                                     By:
                                                     Its:


                                                     MEDSURG INDUSTRIES, INC.

  

                                                     By:
                                                     Its:


                                                     CREATIVE RESEARCH AND
                                                       MANUFACTURING, INC.



                                                     By:
                                                     Its:




                                                     MICHAEL SAHADY

                                                     Date:

332647.1


                                       -6-

<PAGE>


                                   EXHIBIT "A"



                                  May 24, 1996



The Board of Directors
Isolyser Company, Inc.
MedSurg Industries, Inc.
Creative Research and Manufacturing, Inc.

Gentlemen:

         Effective  immediately,  I hereby  resign  as a member  of the Board of
Directors.

                                   Sincerely,




                                 Michael Sahady



332647.1


                                       -7-


                        AMENDMENT TO EMPLOYMENT AGREEMENT


         THIS AMENDMENT TO EMPLOYMENT  AGREEMENT (this  "Amendment") is made and
entered into as of the 31st day of December,  1996, by Isolyser Company, Inc., a
Georgia  corporation  (hereinafter  "Isolyser"),  MedSurg  Industries,  Inc.,  a
Georgia  corporation  formerly known as MedSurg  Acquisition Corp.  (hereinafter
"MedSurg"),  Creative Research and  Manufacturing,  Inc., a Georgia  corporation
formerly known as Creative Acquisition Corp.  (hereinafter  "Creative Research")
(Isolyser, MedSurg and Creative Research being hereinafter collectively referred
to as the "Company"), and Kenneth Newsome (hereinafter "Newsome").

                              W I T N E S S E T H:

         WHEREAS, the Company and Newsome entered into an Employment  Agreement,
dated as of December 31, 1993 (the "Employment Agreement"); and

         WHEREAS , Newsome has resigned his position as an executive officer of
the Company and the Company has accepted such resignation; and

         WHEREAS,  the  Company  and  Newsome  desire  to amend  the  Employment
Agreement,  upon the terms and conditions set forth herein,  to memorialize  the
terms of such resignation.

         NOW,  THEREFORE,  for  and in  consideration  of the  mutual  covenants
contained  herein,  the parties  hereto,  each intending to be legally bound, do
hereby agree as follows:

         1. Employment Termination. Effective December 31, 1996, Newsome resigns
his employment with the Company, and the Company accepts such resignation on the
terms and conditions set forth in this Agreement.

         2.       Severance Benefits.

                  (a)  Consulting  Payments.  Until  that date (the  "Expiration
Date")  which is the earlier to occur of June 30, 1997 or that date on which the
new business  venture in which Newsome is  participating  shall receive funding,
the Company shall pay to Newsome a consulting fee (the "Consulting  Fee") at the
rate of  $135,000  per annum.  The  Consulting  Fee shall be payable in the same
manner as Newsome's salary has previously been paid by the Company.  The Company
shall be entitled to offset against the  Consulting  Fee any applicable  payroll
taxes.

                  (b) Health Insurance.  Subject to Newsome's proper election to
continue  his health  insurance  coverage  under  COBRA for  himself  and/or his
dependents,  the Company will pay for or reimburse Newsome for the cost of COBRA
coverage through the Expiration Date.

                  (c) No Other  Benefits.  Except as set forth in this Section 2
and in Section 4 below,  Newsome acknowledges that neither he nor his dependents
shall be entitled to participate in any other compensation  (including,  without
limitation, unused leave at January 1, 1997) or fringe benefits which are or may
from time to time be provided by the Company including, without limitation, such
fringe benefits described in Section 5(c) of the Employment Agreement.

391471.1

<PAGE>




         3.  Protective  Covenants.  Newsome  acknowledges  and agrees  that the
protective  covenants  set  forth in  Section  10 of the  Employment  Agreement,
including,  without limitation, the covenants against disclosure of confidential
information,  solicitation of Company  employees and customers,  and competition
shall:

                  (a) Continue in full force and effect and are hereby  ratified
and confirmed by Newsome, and

                  (b) Survive  this  Amendment in  accordance  with the terms of
such  covenants  and shall be binding upon Newsome for the  respective  survival
times set forth in the Employment Agreement from a December 31, 1996 termination
date.

         4.       Other Matters.

                  (a) Except for those  provisions of the  Employment  Agreement
which by their  respective  nature  survive the  termination  of the  Employment
Agreement  (including,   without  limitation,   Section  10  of  the  Employment
Agreement),   the  parties   acknowledge  that  the  Employment   Agreement  has
terminated.

                  (b) Newsome  acknowledges  that he has submitted  vouchers and
received  reimbursement  for all  business  expenses  to  which  he is  entitled
reimbursement  under Section 7 of the  Employment  Agreement.  The Company shall
have no further obligations under Section 7 of the Employment Agreement.

                  (c) Prior to the execution  and delivery of this  amendment by
the parties,  the Compensation  Committee has awarded to Newsome a non-qualified
stock  option  under the  Company's  Stock Option Plan for the purchase of up to
124,000  shares of common  stock of  Isolyser  upon and subject to the terms and
conditions  set forth in a separate  non-qualified  stock option  agreement (the
"Stock Option")  entered into between Isolyser and Newsome in replacement of all
stock options  previously  awarded to Newsome which have been canceled by virtue
of such Stock Option. This Amendment does not modify the Stock Option.

         5.       Releases.

                  (a) In consideration of the covenants of the Company contained
in this  Amendment,  Newsome hereby  irrevocably and  unconditionally  releases,
waives, remises, forever discharges and agrees not to sue the Company and/or any
and all parent companies, divisions, subsidiaries,  affiliates and other related
entities of the  Company,  as well as each of the  Company's  past,  present and
future owners, directors, officers, employees, and the predecessors,  successors
and assigns of each of them in their personal or corporate  capacities,  and all
of their attorneys (collectively, the "Released Parties"), from and with respect
to any and all liabilities,  actions,  claims,  obligations,  damages, causes of
action,  contracts,  accounts,  agreements and demands of any nature  whatsoever
that  Newsome  has,  may have or may claim to have  against any of the  Released
Parties,  whether  known or unknown,  liquidated or  unliquidated,  in law or in
equity, whether arising under any local, state or federal  constitutions,  laws,
rules or  regulations,  or under the common law or  statutory  law of the United
States  prohibiting  employment   discrimination  based  on  race,  color,  sex,
religion, handicap disability, national

391471.1


                                       -2-

<PAGE>



origin or any other protected  category or  characteristic,  including the Civil
Rights Act of 1964,  the Civil Rights Act of 1986 or 1871,  the  National  Labor
Relations Act or any other federal, state or local human rights, civil rights or
employment  discrimination  statute,  including  any claim arising under the AGE
DISCRIMINATION  IN  EMPLOYMENT  ACT OF 1967, as amended  ("ADEA"),  any rules or
regulations  arising  under  such  laws,  and  any and all  claims  relating  to
Newsome's employment or termination thereof,  including, but not limited to, any
claims under the doctrines of defamation,  libel, slander,  invasion of privacy,
interference  with  contractual  relations,  or implied  contracts  arising from
employee  handbooks,  policies,  manuals or statements of procedure and wrongful
discharge,  it being the  intention  of the  Company  and  Newsome  to make this
release as broad and as general as the law permits to include in addition to the
foregoing all possible claims which arose or might arise out of contract or tort
under state or federal law.

                  (b) In consideration of the covenants of Newsome  contained in
this Amendment,  the Company hereby  irrevocably and  unconditionally  releases,
waives,  remises,  forever  discharges and agrees not to sue, or otherwise claim
payment to be due to or from  Newsome,  his heirs or  personal  representatives,
arising out of Newsome's capacity as an employee, stockholder, officer or former
officer,  from and with  respect to any and all  liabilities,  actions,  claims,
obligations,  damages,  causes of action,  contracts,  accounts,  agreements and
demands  of any  nature  whatsoever  that the  Company  or any of the  Company's
stockholders,  officers or employees  has, may have or may claim to have against
Newsome,  whether  known or unknown,  liquidated or  unliquidated,  in law or in
equity, whether arising under any local, state or federal  constitutions,  laws,
rules or regulations, or under common law or statutory law of the United States,
and any and all claims  relating to  Newsome's  employment,  including,  but not
limited  to, any claims  under the  doctrines  of  defamation,  libel,  slander,
invasion of privacy,  or interference with contractual  relations,  it being the
intention  of the  Company  and  Newsome  to make this  release  as broad and as
general as the law permits to include in addition to the  foregoing all possible
claims which arose or might arise out of contract or tort under state or federal
law.

                  (c) Nothing contained in Subsection (a) or (b) of this Section
5 shall restrict or otherwise  impair in any manner the rights or obligations of
any parties  arising  under and by virtue of (i) the  Employment  Agreement,  as
amended by this Amendment, (ii) this Amendment, or (iii) the Stock Option.

         6. Return of Property.  Newsome hereby warrants and represents that, as
of the date of this  Amendment,  Newsome  has  delivered  to the  Company or its
designee (a) all keys to the Company's offices,  (b) all Company credit cards in
his  possession,  and (c) any Company  files,  records or equipment  (including,
without  limitation,  the  Company's  computer  and printer,  together  with all
software  and magnetic  media of the Company  associated  therewith,  located at
Newsome's  residence)  kept in or  maintained  by him in his office or elsewhere
(including all copies thereof).

         7. Workers'  Compensation.  Newsome  represents that, as of the date of
this  Amendment,  he has not, and agrees that he will not, make any claims under
Workers'  Compensation  Insurance with respect to Newsome's period of employment
at the Company.


391471.1


                                       -3-

<PAGE>




         8. Consulting  Services.  For the consideration  elsewhere set forth in
this  Amendment,  Newsome  agrees to serve as a consultant to the Company as set
forth in this  Section.  Upon the request from time to time of any  president or
vice  president of the Company,  Newsome will (i) advise as requested  regarding
the management and operations of the Company, (ii) provide information about the
Company's prior business  transactions and performance,  and (iii) provide other
assistance and information which is reasonably  desired by the Company and which
is of the type consistent  with the services  provided by Newsome to the Company
immediately prior to his resignation from employment.  Newsome agrees to provide
a minimum of 32 hours per month of such consulting services until the Expiration
Date at  which  time  the  consulting  services  shall  cease.  When  reasonably
feasible,  Newsome may provide such advice,  information and assistance over the
telephone. From time to time the Company may request, however, that Newsome meet
with  representatives  of the Company at the offices or other  facilities of the
Company to provide  such  consulting  services.  Upon  submission  by Newsome of
vouchers in form  reasonably  satisfactory  to the  Company,  the Company  shall
reimburse Newsome for all reasonable third party out-of-pocket expenses directly
incurred by Newsome  (other than overhead  expenses) in the  performance  of his
consulting  services hereunder in a manner consistent with the regular practices
of the  Company.  Newsome  agrees to  coordinate  in  advance  with  appropriate
personnel  of the  Company  prior to  incurring  any such  expenses  other  than
immaterial expenses.

         9.       Miscellaneous.

                  (a) Any  capitalized  terms which are not defined herein shall
have the meanings set forth in the Employment Agreement.

                  (b) Each  party  agrees  that he or it will  refrain  from any
communication  to third parties which  denigrates,  disparages or criticizes the
other party hereto.

                  (c)  This   Agreement  and  all  the  terms,   provisions  and
conditions  hereof  shall be  binding  upon and inure to the  benefit  of and be
enforceable by the heirs and personal representatives of Newsome.

                  (d) The Company and Newsome  represent that, as of the date of
execution  and  delivery  of this  Amendment  by each of them,  no breach of the
Employment Agreement, as amended by this Amendment, has occurred which is within
the actual knowledge of the parties so representing.







                         [SIGNATURES ON FOLLOWING PAGE]

391471.1


                                       -4-

<PAGE>


         IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be
executed and delivered as of the date first above written.

                                                     ISOLYSER COMPANY, INC.



                                                     By:
                                                     Its:


                                                     MEDSURG INDUSTRIES, INC.



                                                     By:
                                                     Its:


                                                     CREATIVE RESEARCH AND
                                                       MANUFACTURING, INC.



                                                     By:
                                                     Its:




                                                     KENNETH NEWSOME

                                                     Date:

391471.1


                                       -5-

                    SIXTH AMENDMENT OF ISOLYSER COMPANY, INC.
                                STOCK OPTION PLAN

         WHEREAS,  by at least a majority vote of the holders of the outstanding
capital stock of Isolyser Company, Inc. (the "Company") who voted on said matter
at the annual  shareholders  meeting of the Company held on April 28, 1992,  the
Company approved,  ratified and affirmed that certain Stock Option and Alternate
Rights Plan (as amended to date, the "Plan"); and

         WHEREAS,  by at least a majority vote of the holders of the outstanding
capital  stock of the  Company  who  voted on said  matter  at the  shareholders
meetings of the Company held (i) on April 19, 1994, the Company amended the Plan
to increase  the number of shares  reserved for options and subject to alternate
rights under the Plan from 1,400,000  shares of common stock to 1,566,076 shares
of common stock (as adjusted for the Company's October 2, 1995 two for one stock
split) and to change the name of the Plan to "Stock Option Plan",  (ii) on April
27, 1995, the Company amended the Plan to increase the number of shares reserved
for options and subject to  alternate  rights  under the Plan from  1,566,076 to
2,400,000 shares of common stock (as adjusted for the Company's  October 2, 1995
two for one stock split), (iii) on May 16, 1996, the Company amended the Plan to
increase  the number of shares  reserved  for options  and subject to  alternate
rights under the Plan from  2,400,000 to 3,600,000  shares of common stock,  and
(iv) on August 30,  1996,  the Company  amended  the Plan for  various  purposes
including,  without limitation, an increase in the number of shares reserved for
options and subject to alternate rights from 3,600,000 to 4,400,000; and

         WHEREAS,  the Board of Directors has resolved to further amend the Plan
as hereinbelow more particularly set forth.

         NOW, THEREFORE, the Plan is hereby amended as follows:

         1. Defined Terms.  Initially  capitalized terms used in this Amendment
which are not otherwise defined by this Amendment are used with the same meaning
ascribed to such terms in the Plan.

         2. Amendment. Section 5.1 of the Plan is amended by deleting the number
"4,400,000"  (such figure having been adjusted to reflect the Company's  October
2, 1995 two for one stock split) appearing therein and inserting in lieu thereof
the number  "4,800,000"  (such  figure  having  been  adjusted  to  reflect  the
Company's October 2, 1995 two for one stock split).

         3.  Effectiveness.  Section  2  of  this  Amendment  shall  not  become
effective  unless and until such  provisions are approved by at least a majority
vote of the holders of the outstanding  capital stock of the Company present, or
represented,  and  entitled to vote on such matter at a meeting of  shareholders
duly called and convened within one (1) year following the date hereof.




422704.1

<PAGE>


         4.       Ratification.  Except as hereinabove amended and modified, the
Plan  is  approved,  ratified  and  affirmed  without  further  modification  or
amendment.


         IN WITNESS  WHEREOF,  the Company has caused this Sixth Amendment to be
executed on April 4, 1997,  in  accordance  with Article XII of the Plan and the
authority provided by the Board of Directors.

                                    ISOLYSER COMPANY, INC.



                                    By:
                                    Name:            Dan R. Lee
                                    Title:           Vice President and Chief
                                                      Financial Officer

422704.1


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission